Negative pathology of ureteral carcinoma significantly delaying the diagnosis of the primary tumor of osteoblastic metastases: A case report and review of the literature

Wu,Ya‑Lan; Liu,Yong‑Mei; Chen,Hui‑Jiao; Wang,Yong‑Sheng; Lu,You

doi:10.3892/ol.2016.5023

Negative pathology of ureteral carcinoma significantly delaying the diagnosis of the primary tumor of osteoblastic metastases: A case report and review of the literature

Authors:
- Ya‑Lan Wu
- Yong‑Mei Liu
- Hui‑Jiao Chen
- Yong‑Sheng Wang
- You Lu
View Affiliations

Affiliations: Department of Oncology, Chengdu Shang Jin Nan Fu Hospital, Chengdu, Sichuan 610041, P.R. China, Department of Thoracic Oncology, Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan 610041, P.R. China, Department of Pathology, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan 610041, P.R. China
Published online on: August 16, 2016 https://doi.org/10.3892/ol.2016.5023
Pages: 2417-2420
Copyright: © Wu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Ureteral urothelial carcinoma (UC) is a rare malignant tumor. The most common clinical manifestations of ureteral UC are hematuria, increased urinary frequency, dysuria and pain. The diagnosis of ureteral UC is made via radiography, endoscopy and pathology. Although osteoblastic destruction is usually observed in metastasis of prostate cancer, UC can also be a reason for osteoblastic metastasis. The present study reports the case of a 66‑year‑old man presenting with osteoblastic metastases, in which the primary tumor was finally diagnosed as a ureteral UC. However, the lack of pathological evidence significantly delayed the diagnosis of the primary tumor (>6 months), even though the results of radiographic examination, and the type and mode of bone metastases significantly suggested a ureteral UC. The case reveals that a suitable screening test should be recommended for patients at high risk due to the possibility of a negative pathology result for ureteral UC. Additionally, a more efficient diagnostic method is required. Moreover, the possibility of new diagnostic criterion that do not rely on the pathology of primary foci in ureteral UC should be considered in future.

View Figures

View References

1	Bennington J and Beckwith JB: Tumors of the kidney, renal pelvis and ureterAtlas of Tumor Pathology. 2nd series, fasc 12. Armed Forces Institute of Pathology; pp. 320–322. 1975
2	Winalski CS, Lipman JC and Tumeh SS: Ureteral Neoplasms. Radiographics. 10:271–283. 1990. View Article : Google Scholar : PubMed/NCBI
3	Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou-Redorta J and Rouprêt M: European Association of Urology (EAU): EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol. 59:997–1008. 2011. View Article : Google Scholar : PubMed/NCBI
4	Margulis V, Shariat SF, Matin SF, Kamat AM, Zigeuner R, Kikuchi E, Lotan Y, Weizer A, Raman JD and Wood CG: Upper Tract Urothelial Carcinoma Collaboration: Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer. 115:1224–1233. 2009. View Article : Google Scholar : PubMed/NCBI
5	Clark PE, Spiess PE, Agarwal N, et al: Bladder Cancer: National Comprehensive Cancer Network guidelines. https://www.nccn.org/professionals/physician_gls/f_guidelines.asp#bladderAccessed. May 21–2015
6	Rouprêt MI, Babjuk M, Compérat E, Zigeuner R, Sylvester RJ, Burger M, Cowan NC, Böhle A, Van Rhijn BW, Kaasinen E, et al: European Association of Urology guidelines on upper urinary tract urothelial cell carcinoma: 2015 update. Eur Urol. 68:868–879. 2015. View Article : Google Scholar : PubMed/NCBI
7	Batata MA, Whitmore WF, Hilaris BS, Tokita N and Grabstald H: Primary carcinoma of the ureter: A prognostic study. Cancer. 35:1626–1632. 1975. View Article : Google Scholar : PubMed/NCBI
8	Saitoh H, Hida M, Nakamura K and Satoh T: Distant metastasis of urothelial tumors of the renal pelvis and ureter. Tokai J Exp Clin Med. 7:355–364. 1982.PubMed/NCBI
9	Goldman SM, Fajardo AA, Naraval RC and Madewell JE: Metastatic transitional cell carcinoma from the bladder: Radiographic manifestions. AJR Am J Roentgenol. 132:419–425. 1979. View Article : Google Scholar : PubMed/NCBI
10	Krabbe LM, Bagrodia A, Westerman ME and Margulis V: Diagnosis and management of upper tract urothelial carcinoma. Minerva Urol Nefrol. 66:37–48. 2014.PubMed/NCBI
11	Yakoubi R, Colin P, Seisen T, Léon P, Nison L, Bozzini G, Shariat SF and Rouprêt M: Radical nephroureterectomy versus endoscopic procedures for the treatment of localised upper tract urothelial carcinoma: A meta-analysis and a systematic review of current evidence from comparative studies. Eur J Surg Oncol. 40:1629–1634. 2014. View Article : Google Scholar : PubMed/NCBI
12	Raman SP and Fishman EK: Bladder malignancies on CT: The underrated role of CT in diagnosis. AJR Am J Roentgenol. 203:347–354. 2014. View Article : Google Scholar : PubMed/NCBI
13	Brem SS, Bierman PJ, Brem H, Butowski N, Chamberlain MC, Chiocca EA, DeAngelis LM, Fenstermaker RA, Friedman A, Gilbert MR, et al: Central nervous system cancers. J Natl Compr Canc Netw. 9:352–400. 2011.PubMed/NCBI
14	Larre S, Catto JW, Cookson MS, Messing EM, Shariat SF, Soloway MS, Svatek RS, Lotan Y, Zlotta AR and Grossman HB: Screening for bladder cancer: Rationale, limitations, whom to target, and perspectives. Eur Urol. 63:1049–1058. 2013. View Article : Google Scholar : PubMed/NCBI
15	Xylinas E, Kluth LA, Rieken M, Karakiewicz PI, Lotan Y and Shariat SF: Urine markers for detection and surveillance of bladder cancer. Urol Oncol. 32:222–229. 2014. View Article : Google Scholar : PubMed/NCBI
16	Green DA, Rink M, Xylinas E, Matin SF, Stenzl A, Roupret M, Karakiewicz PI, Scherr DS and Shariat SF: Urothelial carcinoma of the bladder and the upper tract: Disparate twins. J Urol. 189:1214–1221. 2013. View Article : Google Scholar : PubMed/NCBI
17	Zincke H, Aguilo JJ, Farrow GM, Utz DC and Khan AU: Significance of urinary cytology in the early detection of transitional cell cancer of the upper urinary tract. J Urol. 116:781–783. 1976.PubMed/NCBI
18	Ho KJ and Kuo SH: Urinary beta-glucuronidase activity as an initial screening test for urinary tract malignancy in high risk patients. Comparison with conventional urine cytologic evaluation. Cancer. 76:473–478. 1995. View Article : Google Scholar : PubMed/NCBI